The Global Positioning System for Human Health

Before diagnosis. Before symptoms. There’s Cytognosis.

Transforming lives before disease defines them.

Our Vision

To transform healthcare from reactive treatment to proactive preservation of healthspan.

Our Mission

To detect and preempt the earliest disease signatures, years before clinical onset.

Our Values

To make precision health a human right, not a privilege of wealth or geography.

The Story Behind the Science

37 Years. 10 Misdiagnoses. 1 Revelation.

For 37 years, the founder navigated a labyrinth of misdiagnoses, collecting mismatched puzzle pieces of a complex clinical picture. Standard treatments failed as medicine chased symptoms rather than causes. The breakthrough emerged only through personal genomic analysis, which identified a critical mutation in TBX1.

This diagnostic journey exposed a fundamental systemic flaw: healthcare acts reactively, waiting for disease to manifest, rather than proactively preserving health. This creates three critical blindspots:

  • Mechanistic Blindness (We treat symptoms, not root causes): Just as a "cough" may stem from flu or strep, complex conditions like depression encompass distinct endotypes. Without mechanistic diagnostics, clinicians default to trial-and-error.
  • Complexity Blindness (We fight fires, not sparks): Disease follows a trajectory. Alzheimer's biomarkers emerge 15–30 years before decline. By the time symptoms appear, disease has crossed a critical phase transition where damage is irreversible.
  • Temporal Blindness (We take snapshots, not movies): You cannot predict a hurricane from a single photo. Disease is dynamic, yet annual blood panels cannot distinguish pathological deviation from natural variation, leaving the prevention window invisible.

Cytognosis Platform

The Global Positioning System for Human Health

The Cytognosis Platform operates as a Global Positioning System for Health, moving beyond reactive diagnosis to proactive preservation. Just as GPS requires a map, satellites, and a navigator, our unified architecture integrates three core technologies:

Together, these technologies transform healthcare from reactive diagnosis ("you have diabetes") to proactive navigation ("your metabolic coordinates are shifting; adjust circadian timing to restore trajectory").

Cytoverse™

The Map

Cytoscope™

The Tracker

Cytonome™

The Navigator

Challenges

  • Mechanistic Blindness: Treating symptoms as monolithic diseases (e.g., "depression") rather than distinct biological endotypes.
  • Fragmented View: Single modalities like genetics miss the system-wide complexity of true biology.
  • Population Averages: "One-size-fits-all" standards ignore individual biological uniqueness.
  • Siloed Analysis: Studying diseases in isolation obscures shared mechanisms and drivers.

Our Solution: The Universal Coordinate System

  • Universal Coordinates: Replaces binary labels (sick/healthy) with continuous, quantitative health mapping.
  • Multimodal Integration: Fuses multi-omics and function into unified, predictive models.
  • Cross-Disorder Learning: Reveals shared molecular drivers across seemingly unrelated conditions.
  • Disentangled Axes: Isolates specific causal pathways to ensure interpretable, actionable insights.

Challenges

  • Temporal Blindness: Sparse annual snapshots miss the dynamic rate of change that signals disease.
  • Incomplete Profiles: Single markers (like glucose) fail to capture broad system stress.
  • Static Hardware: Fixed sensors cannot adapt to new discoveries or evolving personal risks.
  • Generic Baselines: Population norms mask continuous, individual-specific deviations.

Our Solution: The Continuous Health Tracking System

  • Continuous Tracking: High-frequency monitoring to capture the full trajectory of biological change.
  • High-Dimensional Sensing: 100+ simultaneous markers for a holistic view of molecular context.
  • Software-Defined Biology: Over-the-air updates adapt monitoring targets as risk profiles evolve.
  • Personalized Calibration: Establishes a self-referential baseline to detect your earliest warning signs.

Challenges

Raw data without context is just noise:

  • Centralized Risk: Cloud-based analyses create privacy paradoxes and single points of failure.
  • Contextual Blindness: Data stripped of environment and lifestyle loses predictive power.
  • Reactive Intervention: Acting only after irreversible damage has occurred ("break-fix").
  • Static Guidance: Generic advice ignores dynamic metabolic and genetic reality.

Our Solution: The Personal Health Navigation System

Cytonome steers your unique trajectory:

  • Privacy-First Edge AI: On-device processing ensures raw data never leaves your control.
  • Multimodal Context: Grounds biology in real-world behavior and environment.
  • Causal Forecasting: Simulates future trajectories to identify tipping points early.
  • Micro-Interventions: Precise, mechanistic course corrections to restore optimal baselines.

Our Roadmap

2025 - 2030

Phase 1: Foundation

Building the core infrastructure. We are developing the Neuroverse and Immunoverse models, aggregating 10M+ cells of multi-omics data, and validating our programmable sensor technology in vitro.

$100M R&D Investment
50+ Biomarkers
2 Foundation Models
Open Science
2030 - 2035

Phase 2: Clinical Translation

From research to reality. We will launch direct-to-consumer pilots, achieve FDA clearances for autoimmune and mental health panels, and demonstrate clinical efficacy in longitudinal cohorts.

1M Active Users
5 FDA Indications
$380M Annual Revenue
95% Sensitivity
2035 - 2040

Phase 3: Global Democratization

Universal access. We will deploy in emerging markets with subsidized pricing models, ensuring the geography lottery no longer dictates health outcomes.

25M Global Users
50+ Countries
1M Lives Saved
$100B Costs Saved

Our Strategy

The Helix Framework

For centuries, humanity faced a false choice: pursue profit or pursue purpose. The Helix Framework reveals this dichotomy as an illusion. Just as yin and yang are complementary aspects of a unified whole, each containing the seed of the other. Profit and purpose are two strands of the same organizational DNA.

When structured correctly, profit amplifies purpose and purpose generates profit in an upward spiral of sustainable impact. The Cytognosis Foundation serves as the first comprehensive implementation, demonstrating how mission-locked organizations can attract substantial capital while maintaining unwavering commitment to global health equity.

"Capital is oxygen for moonshots. Without it, transformative ideas suffocate before reaching the patients they could save. But here's the paradox: the moment money shifts from catalyst to purpose, we fail. True innovation emerges when mission alignment is encoded in our organizational DNA, as immutable as genetic code itself. Like the double helix, profit and purpose spiral upward together; neither can exist without the other, each stabilizing and propelling its complement."

Shahin Mohammadi, Founder

Read more about the Helix Framework on our blog (coming soon).